- Home
- IMMP vs BACQ Comparison
IMMP vs BACQ Comparison
Compare IMMP & BACQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- BACQ
- Stock Information
- Founded
- IMMP 1987
- BACQ 2024
- Country
- IMMP Australia
- BACQ United States
- Employees
- IMMP N/A
- BACQ N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- BACQ
- Sector
- IMMP Health Care
- BACQ
- Exchange
- IMMP Nasdaq
- BACQ NYSE
- Market Cap
- IMMP 211.1M
- BACQ 333.2M
- IPO Year
- IMMP N/A
- BACQ 2024
- Fundamental
- Price
- IMMP $1.86
- BACQ $10.15
- Analyst Decision
- IMMP Buy
- BACQ
- Analyst Count
- IMMP 2
- BACQ 0
- Target Price
- IMMP $8.50
- BACQ N/A
- AVG Volume (30 Days)
- IMMP 648.0K
- BACQ 301.3K
- Earning Date
- IMMP 05-16-2025
- BACQ 01-01-0001
- Dividend Yield
- IMMP N/A
- BACQ N/A
- EPS Growth
- IMMP N/A
- BACQ N/A
- EPS
- IMMP N/A
- BACQ N/A
- Revenue
- IMMP $3,019,249.00
- BACQ N/A
- Revenue This Year
- IMMP $11.25
- BACQ N/A
- Revenue Next Year
- IMMP $10.22
- BACQ N/A
- P/E Ratio
- IMMP N/A
- BACQ $112.74
- Revenue Growth
- IMMP 24.11
- BACQ N/A
- 52 Week Low
- IMMP $1.32
- BACQ $9.80
- 52 Week High
- IMMP $3.34
- BACQ $10.14
- Technical
- Relative Strength Index (RSI)
- IMMP 53.43
- BACQ N/A
- Support Level
- IMMP $1.44
- BACQ N/A
- Resistance Level
- IMMP $2.71
- BACQ N/A
- Average True Range (ATR)
- IMMP 0.17
- BACQ 0.00
- MACD
- IMMP 0.05
- BACQ 0.00
- Stochastic Oscillator
- IMMP 29.75
- BACQ 0.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About BACQ BLEICHROEDER ACQUISITION CORP. I
Bleichroeder Acquisition Corp I is a blank check company.